statistiche ricercatore

TOSI, GIOVANNA

Distribuzione geografica

Continente	#
NA - Nord America	10.077
EU - Europa	8.517
AS - Asia	4.207
SA - Sud America	468
AF - Africa	52
Continente sconosciuto - Info sul continente non disponibili	8
OC - Oceania	4
Totale	23.333

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	9.890
IT - Italia	4.320
UA - Ucraina	1.555
SG - Singapore	1.428
CN - Cina	739
VN - Vietnam	674
TR - Turchia	653
DE - Germania	580
SE - Svezia	577
HK - Hong Kong	512
FI - Finlandia	428
BR - Brasile	419
IE - Irlanda	298
RU - Federazione Russa	242
GB - Regno Unito	227
FR - Francia	134
CA - Canada	126
IN - India	57
MX - Messico	49
PL - Polonia	42
JP - Giappone	39
BE - Belgio	32
ZA - Sudafrica	25
ES - Italia	22
AR - Argentina	18
BD - Bangladesh	18
NL - Olanda	17
IQ - Iraq	15
KR - Corea	11
LT - Lituania	11
MA - Marocco	10
PK - Pakistan	10
AE - Emirati Arabi Uniti	8
EC - Ecuador	8
EU - Europa	8
CH - Svizzera	7
IR - Iran	7
CZ - Repubblica Ceca	6
SA - Arabia Saudita	6
VE - Venezuela	6
ID - Indonesia	5
PY - Paraguay	5
UZ - Uzbekistan	5
CO - Colombia	4
KE - Kenya	4
LB - Libano	4
TN - Tunisia	4
TW - Taiwan	4
AT - Austria	3
BY - Bielorussia	3
DZ - Algeria	3
JM - Giamaica	3
PE - Perù	3
RS - Serbia	3
AU - Australia	2
BH - Bahrain	2
CI - Costa d'Avorio	2
CL - Cile	2
GR - Grecia	2
HR - Croazia	2
IL - Israele	2
KH - Cambogia	2
MT - Malta	2
NZ - Nuova Zelanda	2
PA - Panama	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AO - Angola	1
BB - Barbados	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
GA - Gabon	1
GY - Guiana	1
HN - Honduras	1
JO - Giordania	1
KW - Kuwait	1
KZ - Kazakistan	1
ME - Montenegro	1
MK - Macedonia	1
NO - Norvegia	1
PH - Filippine	1
PR - Porto Rico	1
PS - Palestinian Territory	1
QA - Qatar	1
TG - Togo	1
Totale	23.333

Salva come PNG Salva come JPEG

Città	#
Milan	3.337
Jacksonville	1.193
Fairfield	928
Chandler	783
Singapore	778
Ashburn	763
Woodbridge	609
Hong Kong	511
Wilmington	429
Ann Arbor	424
Houston	409
Izmir	406
Princeton	398
Seattle	389
Dearborn	366
Beijing	329
Nyköping	297
Dublin	296
Cambridge	287
Dallas	285
Dong Ket	268
Boardman	235
Rome	231
San Mateo	138
The Dalles	127
New York	117
Los Angeles	98
Como	91
Toronto	85
San Diego	76
Ogden	69
Munich	53
Santa Clara	52
São Paulo	51
Düsseldorf	45
Chicago	44
Council Bluffs	44
Tokyo	38
Warsaw	36
Helsinki	35
Hefei	34
Verona	33
Ho Chi Minh City	32
Brussels	31
London	30
Mexico City	28
Nanjing	28
Orem	28
Hanoi	27
Guangzhou	25
Norwalk	25
Turku	22
Boston	21
Phoenix	21
Frankfurt am Main	20
Pune	20
Brooklyn	19
Kunming	19
Johannesburg	18
Denver	17
Falls Church	17
Manchester	17
Stockholm	17
Jinan	16
Washington	16
Montreal	15
St Petersburg	15
Chennai	14
Columbus	14
Poplar	14
Fuzhou	13
San Francisco	13
Amsterdam	11
Belo Horizonte	11
Atlanta	10
San Jose	10
Kocaeli	9
Shanghai	9
Ankara	8
Brasília	8
Buffalo	8
Curitiba	8
Hangzhou	8
Kilburn	8
Nanchang	8
Nuremberg	8
Porto Alegre	8
Querétaro	8
Rio de Janeiro	8
Changsha	7
Hebei	7
Raleigh	7
Salt Lake City	7
Tehran	7
Xian	7
Zhengzhou	7
Auburn Hills	6
Chongqing	6
Guarulhos	6
Miami	6
Totale	16.050

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	239
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	227
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	226
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	204
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	200
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	196
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	195
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	193
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	189
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	186
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	185
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	184
The MHC class II transactivator: prey and hunter in infectious diseases	183
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	182
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	177
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	176
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	174
Autoimmunità e Malattie Autoimmuni	174
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	173
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	169
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	168
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	166
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	165
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	164
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	162
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	161
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	157
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	157
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	156
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	155
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	154
A dual defensive role of CIITA against retroviral infections	153
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	152
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	152
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	151
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	151
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	149
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters	149
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation	148
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	148
MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?	147
Associazione tra genotipo HLA-DQ e suscettibilità al Diabete insulino-Dipendente	147
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	146
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers	145
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	144
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	144
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	144
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	143
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	142
Analysis of microchimerism in thyroid autoimmune diseases	141
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	141
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	141
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	141
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	139
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	139
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	138
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	138
Role of the HLA-DQ genotype in IDDM susceptibility	137
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	135
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for Insulin-Dependent Diabetes Mellitus	135
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	134
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	133
Molecular typing of polymorphic genes by time-resolved fluorescence resonance energy transfer	131
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	131
Tat protein is an HIV-1 encoded SS-chemochine homolog that promotes migrationand upregulates CCR3 on human FceRI+ cells	130
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	130
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	130
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	130
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients.	130
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas	128
HLA-DQB1 typing of north east italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-Enzyme Immunoassay (DEIA)	128
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	128
HTLV-2 Tax-2 transactivator increases the expression and the function of its inhibitor CIITA, the master regulator of HLA-II gene transcription	128
Cellular and molecular aspects of immune response relevant to autoimmune diseases	126
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	125
Associazione tra HLA-DQB1 e diabete giovanile analizzata a livello molecolare per Southern e DEIA	124
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	124
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	124
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	124
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines	123
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	123
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA	122
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	121
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	121
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	120
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	119
HTLV2 influence on pathways regulating proliferation and death in B cell line BJAB	119
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	116
Regulation of HLA antigen expression in HIV infected cells	116
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect	115
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection.	115
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	114
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	114
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	114
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	114
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	113
Approcci immunogenetici per il controllo dell'infezione da retrovirus umani	113
CIITA, the Master Regulator of MHC Class II Gene Transcription, Targets the Viral Transactivator Tax-1 to Inhibit HTLV-I Viral Replication and NFKB Activation	112
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	112
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription	110
Totale	14.661

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	92.784
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	92.784

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.949	0	0	0	0	0	272	83	287	431	102	242	532
2021/2022	1.700	211	223	152	133	42	48	57	123	83	222	159	247
2022/2023	2.159	252	86	120	258	159	493	0	292	312	63	69	55
2023/2024	4.884	816	801	919	824	877	310	50	40	155	20	9	63
2024/2025	2.562	10	45	483	50	107	108	123	141	313	158	220	804
2025/2026	2.859	492	363	187	862	539	416	0	0	0	0	0	0
Totale													23.399